7Lab Pharm
LETRO-LAB
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: 7LAB PHARM
LETRO-LAB Detailed
Trusted 7Lab Pharm Letro-Lab Source
Letro-Lab made by 7Lab Pharm - Official anabolic steroids and pharmaceutical drug supplier is an aromatase inhibiting drug also known as Femara, containing letrozole - anti-estrogen what is used in strength sports bodybuilding and weightlifting for steroids aromatase inhibition and preventing gynecomastia, acne, oily skin, water retention and other estrogenic steroids side effects.
No reviews found
Please log in to write LETRO-LAB review.
Related Offers
US Domestic & International
Dragon Pharma, Europe
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 100 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
60.00 USD
US Domestic & International
Kalpa Pharmaceuticals LTD, India
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 30 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
40.00 USD
Cipla, India
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CIPLA
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CIPLA
Balkan Pharmaceuticals
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 60 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: BALKAN PHARMACEUTICALS
ACTIVE SUBSTANCE: LETROZOLE
FORM: 60 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: BALKAN PHARMACEUTICALS
International
Generic
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 100 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
ACTIVE SUBSTANCE: LETROZOLE
FORM: 100 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
80.00 USD
Hilma Biocare
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 30 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: HILMA BIOCARE
ACTIVE SUBSTANCE: LETROZOLE
FORM: 30 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: HILMA BIOCARE
US Domestic & International
Axiolabs
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: 0.25–1.25 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED (POTENT)
MANUFACTURER: AXIOLABS
40.00 USD
US Domestic & International
British Dragon Pharmaceuticals
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS × 2.5 MG
ACTIVE HALF-LIFE: ~2 DAYS
DOSAGE: MEN 0.5–2.5 MG/DAY
ACNE: REDUCED
WATER RETENTION: MINIMIZED
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
40.00 USD